DK50387A - Rekombinant-humant interleukin-2-praeparat og frem-gangsmaade til dets fremstilling - Google Patents

Rekombinant-humant interleukin-2-praeparat og frem-gangsmaade til dets fremstilling

Info

Publication number
DK50387A
DK50387A DK050387A DK50387A DK50387A DK 50387 A DK50387 A DK 50387A DK 050387 A DK050387 A DK 050387A DK 50387 A DK50387 A DK 50387A DK 50387 A DK50387 A DK 50387A
Authority
DK
Denmark
Prior art keywords
preparation
humant
interleukin
recombinant
procedure
Prior art date
Application number
DK050387A
Other languages
English (en)
Other versions
DK50387D0 (da
Inventor
Toby Miriam Tamblyn
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of DK50387D0 publication Critical patent/DK50387D0/da
Publication of DK50387A publication Critical patent/DK50387A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/55—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK050387A 1986-01-31 1987-01-30 Rekombinant-humant interleukin-2-praeparat og frem-gangsmaade til dets fremstilling DK50387A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/825,133 US4933433A (en) 1986-01-31 1986-01-31 Recombinant interleukin-2 composition and process for making it

Publications (2)

Publication Number Publication Date
DK50387D0 DK50387D0 (da) 1987-01-30
DK50387A true DK50387A (da) 1987-08-01

Family

ID=25243198

Family Applications (1)

Application Number Title Priority Date Filing Date
DK050387A DK50387A (da) 1986-01-31 1987-01-30 Rekombinant-humant interleukin-2-praeparat og frem-gangsmaade til dets fremstilling

Country Status (6)

Country Link
US (1) US4933433A (da)
EP (1) EP0231132A3 (da)
JP (1) JPS62185027A (da)
CA (1) CA1281646C (da)
DK (1) DK50387A (da)
IE (1) IE870239L (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5183746A (en) * 1986-10-27 1993-02-02 Schering Aktiengesellschaft Formulation processes for pharmaceutical compositions of recombinant β-
US5037644A (en) * 1986-10-27 1991-08-06 Cetus Corporation Pharmaceutical compositions of recombinant interleukin-2 and formulation processes
US5004605A (en) * 1987-12-10 1991-04-02 Cetus Corporation Low pH pharmaceutical compositions of recombinant β-interferon
US5078997A (en) * 1988-07-13 1992-01-07 Cetus Corporation Pharmaceutical composition for interleukin-2 containing physiologically compatible stabilizers
US5997856A (en) * 1988-10-05 1999-12-07 Chiron Corporation Method and compositions for solubilization and stabilization of polypeptides, especially proteins
FR2684878B1 (fr) * 1991-12-12 1994-02-11 Roussel Uclaf Composition pharmaceutique stabilisee d'il2 humaine recombinante non glycosylee sous forme reduite et son procede de preparation.
DE4239877C1 (de) * 1992-11-27 1994-03-17 Boehringer Ingelheim Int Stabilisierte Superoxid-Dismutase (SOD)-Zusammensetzung
US6045788A (en) * 1996-02-28 2000-04-04 Cornell Research Foundation, Inc. Method of stimulation of immune response with low doses of IL-2
US6509313B1 (en) 1996-02-28 2003-01-21 Cornell Research Foundation, Inc. Stimulation of immune response with low doses of cytokines
US6921530B1 (en) 1999-09-24 2005-07-26 Cornell Research Foundation, Inc. Low dose IL-2 for potentiation of immunity

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3176491D1 (en) * 1980-03-05 1987-11-26 Miles Lab Pasteurized therapeutically active protein compositions
US4623717A (en) * 1980-03-05 1986-11-18 Miles Laboratories, Inc. Pasteurized therapeutically active protein compositions
US4401756A (en) * 1981-04-14 1983-08-30 Immunex Corporation Process for preparing human interleukin 2
DE3377363D1 (en) * 1982-03-31 1988-08-18 Ajinomoto Kk Gene coding for interleukin-2 polypeptide, recombinant dna carrying said gene, cell lines possessing the recombinant dna,and method for producing interleukin-2 using said cells
DE3378128D1 (en) * 1982-04-20 1988-11-03 Sloan Kettering Inst Cancer Purification of interleukin 2
US4490289A (en) * 1982-09-16 1984-12-25 Hoffmann-La Roche Inc. Homogeneous human interleukin 2
US4518584A (en) * 1983-04-15 1985-05-21 Cetus Corporation Human recombinant interleukin-2 muteins
EP0133767B1 (en) * 1983-08-04 1991-04-03 The Green Cross Corporation Gamma interferon composition
AU3235584A (en) * 1983-08-26 1985-02-28 E.I. Du Pont De Nemours And Company Expression plasmids for directing overproduction of specific proteins
JPS60115528A (ja) * 1983-11-28 1985-06-22 Takeda Chem Ind Ltd ヒトインタ―ロイキン―２蛋白質を含有する抗腫瘍用または免疫機能低下疾患治療用組成物
EP0150067A3 (en) * 1984-01-23 1986-12-30 Takeda Chemical Industries, Ltd. Stable composition of gamma-interferon
US4569790A (en) * 1984-03-28 1986-02-11 Cetus Corporation Process for recovering microbially produced interleukin-2 and purified recombinant interleukin-2 compositions
WO1985004328A1 (en) * 1984-03-28 1985-10-10 Cetus Corporation Pharmaceutical compositions of microbially produced interleukin-2
US4530787A (en) * 1984-03-28 1985-07-23 Cetus Corporation Controlled oxidation of microbially produced cysteine-containing proteins
US4604377A (en) * 1984-03-28 1986-08-05 Cetus Corporation Pharmaceutical compositions of microbially produced interleukin-2
DE3583880D1 (de) * 1984-04-09 1991-10-02 Takeda Chemical Industries Ltd Stabile interleukin-2-zusammensetzung.

Also Published As

Publication number Publication date
DK50387D0 (da) 1987-01-30
JPS62185027A (ja) 1987-08-13
EP0231132A3 (en) 1989-03-15
IE870239L (en) 1987-07-31
US4933433A (en) 1990-06-12
EP0231132A2 (en) 1987-08-05
CA1281646C (en) 1991-03-19

Similar Documents

Publication Publication Date Title
NO872729D0 (no) Cefalosporinhydrat og fremgangsmaate for dets fremstilling.
DK166087D0 (da) Proteiner og fremgangsmaade til fremstilling deraf
DK664887A (da) 3-substituerede 3-aroyloxy-propanaminer og fremgangsmaade til fremstilling deraf
DK162137C (da) Engangsble og fremgangsmaade til fremstilling deraf
DK3687A (da) Polypeptider og fremgangsmaade til fremstilling deraf
DK484587A (da) Antioxidant og fremgangsmaade til fremstilling heraf
DK522487A (da) Imidazopyridinforbindelse og fremgangsmaade til fremstilling deraf
DK313086D0 (da) Phenoxyalkylisoxazol- eller -furanforbindelse og fremgangsmaade til fremstilling deraf
DK491087A (da) Tumor-egress-faktor (egressin) og fremgangsmaade til fremstilling heraf
DK290287A (da) Antibiotika og fremgangsmaade til fremstilling deraf
DK315085D0 (da) Isoinsolinyl-alkyl-piperaziner og fremgangsmaade til fremstilling deraf
DK381886A (da) Medicinsk praeparat og fremgangsmaade til dets fremstilling
DK50387A (da) Rekombinant-humant interleukin-2-praeparat og frem-gangsmaade til dets fremstilling
DK203087D0 (da) Proteiner og fremgangsmaade til fremstilling deraf
DK477287A (da) Pyrido-benzoxadiazin-derivater og fremgangsmaade til fremstilling deraf
DK362987D0 (da) Hexahydroarylquinolizin og fremgangsmaade til fremstilling deraf
DK251087D0 (da) Dopamin-beta-hydrolaseinhibitorer og fremgangsmaade til fremstilling deraf
DK443485A (da) Katalysatormateriale og fremgangsmaade til fremstilling heraf
DK463987A (da) Oprenset enzym og fremgangsmaade til fremstilling heraf
DK338185D0 (da) Antihypertensivt og antianginoest kombinationspraeparat og fremgangsmaade til dets fremstilling
DK660387D0 (da) Maleimidgruppeholdige formstofblandinger og fremgangsmaade til fremstilling deraf
DK160087A (da) Katalysatorkomponent og fremgangsmaade til fremstilling deraf
DK387389A (da) Lipasepraeparat og fremgangsmaade til dets fremstilling
DK50686D0 (da) Difficolforbindelse og fremgangsmaade til fremstilling deraf
DK588887D0 (da) Farmaceutisk praeparat og fremgangsmaade til dets fremstilling

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment